Voyager is leading the development of next-generation AAV capsids—which are the outer viral protein shells that enclose genetic material—with the aim of overcoming the limitations currently ...

Efforts to develop gene therapies for neurological disorders have been held back by the inability of current capsids to robustly transduce neurons in specific brain regions and at safe and cost ...